The relationship between body weight and optimal dosing has not been established through controlled trials
Baseline and interval laboratory monitoring should include: fasting glucose and HbA1c (tirzepatide can cause hypoglycemia in non-diabetic subjects if caloric intake drops too low), lipase and amylase (pancreatitis risk with GLP-1 agonists), liver function tests (AST, ALT, bilirubin), and thyroid panel (TSH, free T3, free T4)
You take certain medications: Long-term use of proton pump inhibitors (for acid reflux) or metformin (for diabetes) can interfere with B12 absorption
Can be used as a short-term pain management option when other pain relievers are not suitable
Self-injecting is not for everyone, and that is completely okay
Manufactured under controlled conditions, it is prepared to support reliable use within research environments